Pilot Trial of Neoadjuvant Sunitinib in Patients With Bulky GIST.
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2016
At a glance
- Drugs Sunitinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Adverse reactions
- 26 Apr 2016 Status changed from active, no longer recruiting to discontinued.
- 24 Sep 2013 Planned end date changed from 1 May 2013 to 1 Sep 2015 as reported by ClinicalTrials.gov.
- 17 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.